Learning from CMS Spend Submission

This webinar happened on 20 Jun, 2017
Dont worry if you missed it, we have it recorded for you.

This webinar will take a high-level approach to Compliance. The presenters will share their own experiences in joining this role as the Sunshine Act was being introduced in USA. Attendees will benefit from learning how a global organization was able to combine resources from technology, operations, sales and legal to roll out a precise and multi-channel reporting solution.

Takeaway From This Webinar:

  • Best practices to follow after spend submission
  • Advanced spend data monitoring using Open Payments data
  • Identifying outliers on the basis of benchmarks
  • Protect yourself from risks of audit and fines even after CMS
  • Improve your compliance programs using data analytics


  • Lessons learnt by the Pharmaceutical manufacturing industry 2013-2017
  • Preparation for changes in the Sunshine Payments Act
  • Adjustments required in internal analytics systems
  • How analytics have assisted other functions within their business

Who Should Attend?

Senior and mid-level Transparency, Corporate Compliance and Legal Professionals from the pharmaceutical manufacturing industry. Pharma Sales Professionals interested in improving their reporting practices via technology.


April Pierce
Transparency Manager, Global Reporting
Shire Pharmaceuticals

Chrissy Bradshaw
Porzio, Bromberg

Elizabeth Bodine
Compliance Analyst
Merz - North America

Co-Speaker & Moderator

Ned Mumtaz
Practice Leader Life Science